Levicept has reported Phase 2 clinical trial results for LEVI-04 [...]

The US Food and Drug Administration (FDA) has reaffirmed that [...]

Tozorakimab has met its primary endpoint in two replicate Phase [...]

FoRx Therapeutics presents preclinical data on FORX-428, a PARG inhibitor [...]

Complement Therapeutics doses first patient in Phase 1/Phase 2 Opti-GAIN [...]

Liver-metabolic disease is linked to increased heart failure risk in [...]

Mestag Therapeutics has raised $40 million and appointed two senior [...]

PolyPid is preparing to submit a New Drug Application for [...]

One-carbon Therapeutics has signed a collaboration with Tempus to generate [...]

From hospital haematology to leading early stage clinical trials, Margaret [...]